Glenmede Trust’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $525K | Buy |
+16,025
| New | +$525K | ﹤0.01% | 895 |
|
|
2023
Q3 | – | Sell |
-16,946
| Closed | -$614K | – | 1362 |
|
|
2023
Q2 | $614K | Hold |
16,946
| – | – | ﹤0.01% | 780 |
|
|
2023
Q1 | $614K | Buy |
16,946
+1,123
| +7% | +$40.7K | ﹤0.01% | 783 |
|
|
2022
Q4 | $564K | Buy |
15,823
+79
| +0.5% | +$2.82K | ﹤0.01% | 807 |
|
|
2022
Q3 | $532K | Sell |
15,744
-63
| -0.4% | -$2.13K | ﹤0.01% | 802 |
|
|
2022
Q2 | $456K | Sell |
15,807
-274,410
| -95% | -$7.92M | ﹤0.01% | 878 |
|
|
2022
Q1 | $9.38M | Sell |
290,217
-266,712
| -48% | -$8.62M | 0.05% | 379 |
|
|
2021
Q4 | $16.2M | Sell |
556,929
-6,746
| -1% | -$197K | 0.08% | 296 |
|
|
2021
Q3 | $15M | Sell |
563,675
-4,254
| -0.7% | -$113K | 0.08% | 284 |
|
|
2021
Q2 | $17.5M | Sell |
567,929
-1,532
| -0.3% | -$47.2K | 0.09% | 250 |
|
|
2021
Q1 | $14.9M | Buy |
569,461
+77,727
| +16% | +$2.03M | 0.08% | 273 |
|
|
2020
Q4 | $12.4M | Sell |
491,734
-38,726
| -7% | -$974K | 0.07% | 297 |
|
|
2020
Q3 | $11.1M | Sell |
530,460
-81,504
| -13% | -$1.7M | 0.07% | 293 |
|
|
2020
Q2 | $14.5M | Sell |
611,964
-170,115
| -22% | -$4.04M | 0.09% | 263 |
|
|
2020
Q1 | $18.5M | Hold |
782,079
| – | – | 0.08% | 288 |
|
|
2019
Q4 | $18.5M | Sell |
782,079
-102,635
| -12% | -$2.43M | 0.08% | 288 |
|
|
2019
Q3 | $24.3K | Sell |
884,714
-162,995
| -16% | -$4.48K | 0.11% | 246 |
|
|
2019
Q2 | $34.7K | Sell |
1,047,709
-237,373
| -18% | -$7.85K | 0.15% | 192 |
|
|
2019
Q1 | $45K | Buy |
1,285,082
+80,417
| +7% | +$2.82K | 0.2% | 145 |
|
|
2018
Q4 | $40K | Buy |
1,204,665
+211,182
| +21% | +$7.02K | 0.2% | 145 |
|
|
2018
Q3 | $50M | Buy |
993,483
+340,677
| +52% | +$17.2M | 0.2% | 149 |
|
|
2018
Q2 | $39.1M | Buy |
652,806
+20,012
| +3% | +$1.2M | 0.17% | 195 |
|
|
2018
Q1 | $25.2M | Hold |
632,794
| – | – | 0.11% | 270 |
|
|
2017
Q4 | $25.2M | Sell |
632,794
-88,303
| -12% | -$3.52M | 0.11% | 270 |
|
|
2017
Q3 | $28.8M | Sell |
721,097
-352,238
| -33% | -$14.1M | 0.13% | 238 |
|
|
2017
Q2 | $33.5M | Hold |
1,073,335
| – | – | 0.16% | 205 |
|
|
2017
Q1 | $33.5M | Sell |
1,073,335
-83,537
| -7% | -$2.61M | 0.16% | 205 |
|
|
2016
Q4 | $29.2M | Sell |
1,156,872
-402,740
| -26% | -$10.2M | 0.16% | 225 |
|
|
2016
Q3 | $38.6M | Sell |
1,559,612
-218,783
| -12% | -$5.41M | 0.22% | 133 |
|
|
2016
Q2 | $36.2M | Sell |
1,778,395
-61,885
| -3% | -$1.26M | 0.22% | 141 |
|
|
2016
Q1 | $28.1M | Sell |
1,840,280
-55,383
| -3% | -$845K | 0.18% | 190 |
|
|
2015
Q4 | $25.5M | Buy |
1,895,663
+702,096
| +59% | +$9.44M | 0.17% | 186 |
|
|
2015
Q3 | $16.7M | Buy |
1,193,567
+1,165,216
| +4,110% | +$16.3M | 0.12% | 272 |
|
|
2015
Q2 | $481K | Buy |
+28,351
| New | +$481K | ﹤0.01% | 958 |
|